14-Day Vonoprazan-Based Bismuth Quadruple Therapy for Treatment-Naïve Patients with Helicobacter pylori Infection: A Retrospective Comparative Study

BACKGROUND: Until now, there is little evidence regarding clinical efficacy of 14-day vonoprazan-based bismuth quadruple therapy (BQT) for Helicobacter pylori (H. pylori) eradication. METHODS: Overall, 65 treatment-naïve patients with H. pylori infection who received 14-day vonoprazan-based BQT regi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Feifei, Xu, Wentao, Shi, Xiaoye, Yu, Honglu, Qi, Xingshun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518141/
https://www.ncbi.nlm.nih.gov/pubmed/37750104
http://dx.doi.org/10.2147/IJGM.S427450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518141/
https://www.ncbi.nlm.nih.gov/pubmed/37750104
http://dx.doi.org/10.2147/IJGM.S427450

Ejemplares similares